Delays in Ureteroscopy and Shockwave Lithotripsy After Ureteral Stent Placement: Impact on Infectious Complications,Resource Use,and Medical Costs

Abstract

Purpose:

To evaluate the effects of ureteral stent duration before ureteroscopy (URS) or extracorporeal shockwave lithotripsy (SWL) on infectious complications, health care resource utilization (HCRU), and costs.

Materials and Methods:

Patients who underwent URS/SWL within 6months of ureteral stent placement were identified from commercial claims, categorized by time from stent placement to URS (0–15, 16–30, 31–60, and >60 days) or SWL (0–15, 16–30, and >30 days), and followed 1-month postprocedure. The relationship between ureteral stent duration and emergency department (ED) visits, inpatient admissions, infectious complications (pyelonephritis/sepsis), imaging, and costs was evaluated.

Results:

Mean time to URS (n = 9276 patients) was 21.3 ± 24.4 days and SWL (n = 4689 patients) was 19.0 ± 24.8 days. Compared with patients who underwent URS within 15 days of ureteral stent placement, URS 31 to 60 days after ureteral stent placement was significantly associated with inpatient admissions (odds ratio [OR] 2.56, 95% confidence interval [CI] 2.03–3.22); infectious complications (OR 2.82, 95% CI 2.09–3.81); imaging (OR 2.12, 95% CI 1.82–2.46); and medical costs (OR 1.49, 95% CI 1.40–1.58). Compared with patients who underwent SWL within 15 days of ureteral stent placement, SWL more than 30 days after ureteral stent placement was significantly associated with ED visits (OR 1.79, 95% CI 1.37–2.34); inpatient admissions (OR 3.34, 95% CI 2.38–4.69); infectious complications (OR 3.54, 95% CI 2.20–5.70); imaging (OR 2.65, 95% CI 2.23–3.15); and medical costs (OR 1.45, 95% CI 1.36–1.54).

Conclusions:

URS or SWL >30 days after ureteral stent placement increased the likelihood of infectious complications, HCRU, and medical costs.